The effect of two frequent amino acid variants of the hepatocyte nuclear factor-1α gene on estimates of the pancreatic β-cell function in Caucasian glucosetolerant first-degree relatives of type 2 diabetic patients

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 11, 1998, Pages 3992-3995

  Urhammer, Søren A ^a   Møller, Ann Merete ^a   Nyholm, Birgit ^b   Ekstrøm, Claus T ^a   Eiberg, Hans ^c   Clausen, Jesper O ^d   Hansen, Torben ^a   Pedersen, Oluf ^a   Schmitz, Ole ^b  

^a STENO DIABETES CENTER   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d The Capital Region   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; ISOLEUCINE; LEUCINE; NUCLEAR FACTOR I;

ADULT; ARTICLE; CAUCASIAN; FEMALE; GENE FREQUENCY; HOMOZYGOTE; HUMAN; INSULIN BLOOD LEVEL; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RELATIVE;

EID: 0031732687     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.11.5228     Document Type: Article

References (13)

1. Yamagata K, Oda N, Kaisaki PJ, et al. 1996 Mutations in the hepatic nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 384:455-458.
2. Lehto M, Tuomi T, Mahtani M, et al. 1997 Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest. 99:582-591.
3. Mahtani MM, Widén E, Lehto M, et al. 1996 Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet. 14:90-94.
4. Urhammer SA, Rasmussen SK, Kaisaki PJ, et al. 1997 Genetic variation in the hepatocyte nuclear factor-1α gene in Danish Caucasians with late-onset NIDDM. Diabetologia. 40:473-475.
5. Urhammer SA, Fridberg M, Hansen T, et al. 1997 A prevalent amimo acid polymorphism at codon 98 of the *;Hepatocyte nuclear factor-1α is associated with reduced serum C-peptide and serum insulin responses to an oral glucose challenge. Diabetes. 46:912-916.
6. Clausen JO, Borch-Johnsen K, Ibsen H, et al. 1996 Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life style factors. J Clin Invest. 98:1195-1209.
7. Andersen L, Dinesen B, Jørgensen PN, Poulsen F, Røder ME. 1983 Enzyme immunoassay for intact insulin in serum and plasma. Clin Chem. 39:578-582.
8. Heding LG. 1975 Specific and direct radioimmunoassay for human C-peptide in serum. Diabetologia. 11:547-548.
9. Faber OK, Mircussen J, Naithani VK, Binder C. 1976 Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin. Hoppe-Seyler's Z Physiol Chem. 357:751-757.
10. Faber OK, Binder C, Marcussen J, et al. 1978 Characterization of seven C-peptide antisera. Diabetes. [Suppl 1]27:170-177.
11. Hopper JL, Mathews JD. 1982 Extensions to multivariate models for pedigree analysis. Ann Hum Genet. 46:373-383.
12. Hörlein A, Grajer KH, Igo-Kemens T. 1993 Genomic structure of the POU-related hepatic transcription factor HNF-1α. Biol Chem Hoppe Seyler. 374:419-425.
13. Henriksen JE, Alford F, Handberg A, et al. 1994 Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J Clin Invest. 94:1196-1204.